BioSpace News Archive

Blood plasma comprises platelets, autologous platelets and cytokines which arouse healing of soft tissue.

The apheresis equipment market was valued at US$ 1,985.83 million in 2018 and it is projected to reach US$ 3,528.44 million in 2027; it is expected to grow at a CAGR of 6.9% from 2019 to 2027.

The Contrast Media Agents market was valued at US$ 2,099.9t million in 2018 and it is projected to reach US$ 2,886.3 million by 2027; it is expected to grow at a CAGR of 3.7% from 2029 to 2027.

According to The Insight Partners market research study titled ‘Endoscopy Devices Market - Global Analysis and Forecasts By Product, Application and End User.

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that it has submitted a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA) for selinexor,

The global genome editing market is expected to reach US$ 10,691.0 million by 2025 from US$ 3,210.1 million in 2017; it is estimated to grow at a CAGR of 17.0% from 2018 to 2027.

The microfluidics market is expected to reach US$ 43,398.7 million in 2027 from US$ 11,851.1 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2020 to 2027.

The pain management devices market is expected to reach US$ 8,388.67 million in 2027 from US$ 4,527.31 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.

The Pacemakers in healthcare market was valued at US$ 5,485.4 million in 2018 and it is projected to reach US$ 10,908.0 million by 2027; it is expected to grow at a CAGR of 8.1% from 2019 to 2027.

Asahi Kasei Medical has decided to expand production capacity of hydrophilic PVDF hollow-fiber membranes for Planova™ BioEX filters at its spinning plant in Oita, Japan.